Identifying the deficiencies of currently available CGM to improve uptake and benefit.

Autor: Barnard-Kelly KD; Spotlight Consultations Ltd, Portsmouth, UK.; Southern Health NHS Foundation Trust, Southampton, UK., Martínez-Brocca MA; Hospital Universitario Virgen Macarena, Seville, Spain., Glatzer T; Roche Diabetes Care, Mannheim, Germany., Oliver N; Imperial College, London, UK.
Jazyk: angličtina
Zdroj: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2024 Aug; Vol. 41 (8), pp. e15338. Date of Electronic Publication: 2024 May 12.
DOI: 10.1111/dme.15338
Abstrakt: Background and Aims: The use of diabetes technologies is increasing worldwide, with health systems facilitating improved access to devices. Continuous glucose monitoring is a complex intervention that provides information on glucose concentration, rate and direction of change, historical data and alerts and alarms for extremes of glucose. These data do not themselves change glycaemia and require translation to a meaningful action for impact. It is, therefore, crucial that such systems advance to better meet the needs of individuals using them.
Methods: Narrative review of the use of, engagement with, limitations and unmet needs of continuous glucose monitoring systems.
Results: CGM devices have made a significant contribution to the self-management of diabetes; however, challenges with access and user experience persist, with multiple limitations to uptake and benefit. These limitations include physical size and implementation, with associated stigma, alarm fatigue, sleep disturbance and the challenge of addressing large volumes of real-time data. Greater personalisation throughout the continuous glucose monitoring journey, with a focus on usability, may improve the benefits derived from the device and reduce the burden of self-management. Healthcare professionals may have unconscious biases that affect the provision of continuous glucose monitors due to deprivation, education, age, ethnicity and other characteristics.
Conclusions: Continuous glucose monitoring exerts a dose-dependent response; the more it is used, the more effective it is. For optimal use, continuous glucose monitors must not just reduce the burden of management in one dimension but facilitate net improvement in all domains of self-management for all users.
(© 2024 Diabetes UK.)
Databáze: MEDLINE
Externí odkaz: